{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:02Z","timestamp":1792083602808,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.burns.2026.108178","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:22:57Z","timestamp":1787152977000},"page":"108178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antifungal efficacy of commercial silver sulfadiazine formulations"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-4264","authenticated-orcid":false,"given":"Mar\u00eda Celeste","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4316-3178","authenticated-orcid":false,"given":"Mar\u00eda Laura","family":"Doumecq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-7861","authenticated-orcid":false,"given":"Luciana","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda In\u00e9s","family":"Etcheverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora L\u00eda","family":"Padola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1626-189X","authenticated-orcid":false,"given":"Mar\u00eda Laura","family":"Chiapparrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Julia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.burns.2026.108178_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/jof9030381","article-title":"Clinical manifestations of human exposure to fungi","volume":"9","author":"Oliveira","year":"2023","journal-title":"J Fungi"},{"key":"10.1016\/j.burns.2026.108178_bib2","author":"Freitas-Xavier","year":"2025"},{"issue":"8","key":"10.1016\/j.burns.2026.108178_bib3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/myc.13264","article-title":"Superficial mycoses, a matter of concern: Global and Indian scenario-an updated analysis","volume":"64","author":"Sharma","year":"2021","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.burns.2026.108178_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2477653","article-title":"Chronic cutaneous and mucosal mucormycosis: rhizopus arrhizus as a major pathogenic fungus","volume":"14","author":"Li","year":"2025","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10.1016\/j.burns.2026.108178_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/sur.2013.134","volume":"17","author":"Norbury","year":"2016","journal-title":"Surg Infect"},{"key":"10.1016\/j.burns.2026.108178_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/sur.2009.024","article-title":"Emerging infections in burns","volume":"10","author":"Branski","year":"2009","journal-title":"Surg Infect"},{"issue":"4","key":"10.1016\/j.burns.2026.108178_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041063","article-title":"Antifungal drug resistance: an emergent health threat","volume":"11","author":"Vitiello","year":"2023","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.burns.2026.108178_bib8","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1007\/s00253-021-11407-7","article-title":"Drug repurposing strategies in the development of potential antifungal agents","volume":"105","author":"Zhang","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.burns.2026.108178_bib9","unstructured":"N. Kumar, R.K. Gupta, and A. Gupta, \u201cA recent advances in the antibacterial potential of sulfadiazine: a review,\u201d World Journal of Pharmaceutical Research."},{"issue":"4","key":"10.1016\/j.burns.2026.108178_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0196-6553(99)70055-6","article-title":"Efficacy of topical silver against fungal burn wound pathogens","volume":"27","author":"Wright","year":"1999","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.burns.2026.108178_bib11","article-title":"Old wine in new bottles: silver sulfadiazine nanotherapeutics for burn wound management","author":"Abul Barkat","year":"2023","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.burns.2026.108178_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112553","article-title":"Antifungal activity of phytotherapeutic preparation of Baccharis species from argentine Puna against clinically relevant fungi","volume":"251","author":"Carrizo","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.burns.2026.108178_bib13","unstructured":"L.K. Branski, A. Al-Mousawi, H. Rivero, M.G. Jeschke, A.P. Sanford, and D.N. Herndon, \u201cEmerging Infections in Burns,\u201d https:\/\/home.liebertpub.com\/sur. Accessed: Nov. 18, 2025. [Online]. Available: https:\/\/www.liebertpub.com\/doi\/10.1089\/sur.2009.024."},{"key":"10.1016\/j.burns.2026.108178_bib14","first-page":"12","article-title":"Antibacterial and antifungal activities in vitro of a novel silver(I) complex with sulfadoxine-salicylaldehyde Schiff base","volume":"225","author":"Oliveira","year":"2022","journal-title":"Polyhedron"},{"issue":"4","key":"10.1016\/j.burns.2026.108178_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1067-1927.2005.130409.x","article-title":"Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy","volume":"13","author":"Gallant-Behm","year":"2005","journal-title":"Wound Repair Regen"},{"issue":"11","key":"10.1016\/j.burns.2026.108178_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab444","article-title":"Antifungal susceptibility testing: a primer for clinicians","volume":"8","author":"Wiederhold","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.burns.2026.108178_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2019.06.013","article-title":"Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis","volume":"95","author":"Lewis","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.burns.2026.108178_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14787210.2022.2044795","article-title":"Prevention and treatment of burn wound infections: the role of topical antimicrobials","volume":"20","author":"Ozhathil","year":"2022","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"4","key":"10.1016\/j.burns.2026.108178_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nano.2011.07.005","article-title":"Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine","volume":"8","author":"Brandt","year":"2012","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"6","key":"10.1016\/j.burns.2026.108178_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00004630-198911000-00009","article-title":"The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis","volume":"10","author":"Heggers","year":"1989","journal-title":"J Burn Care Rehabil"},{"issue":"2","key":"10.1016\/j.burns.2026.108178_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.burns.2018.05.014","article-title":"Comparative study of Silver Sulfadiazine with other materials for healing and infection prevention in burns: a systematic review and meta-analysis","volume":"45","author":"N\u00edmia","year":"2019","journal-title":"Burns"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030541792600330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030541792600330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:31:33Z","timestamp":1792081893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030541792600330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S030541792600330X"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2026.108178","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal efficacy of commercial silver sulfadiazine formulations","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2026.108178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108178"}}